Detection and characterization of classical and “uncommon” exon 19 Epidermal Growth Factor Receptor mutations in lung cancer by pyrosequencing

BACKGROUND: The management of advanced stage non-small cell lung cancer is increasingly based on diagnostic and predictive analyses performed mostly on limited amounts of tumor tissue. The evaluation of Epidermal Growth Factor Receptor (EGFR) mutations have emerged as the strongest predictor of resp...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Righi, Luisella, Cuccurullo, Alessandra, Vatrano, Simona, Cappia, Susanna, Giachino, Daniela, Giuli, Paolo De, Ardine, Mara, Novello, Silvia, Volante, Marco, Scagliotti, Giorgio V, Papotti, Mauro
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2013
Matèries:
Technical Advance
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3608975/
https://ncbi.nlm.nih.gov/pubmed/23497146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-114
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars